BANK OF MONTREAL /CAN/ - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 181 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$318,000
+404.8%
1,460
+192.0%
0.00%
Q4 2020$63,0000.0%500
-24.2%
0.00%
Q3 2020$63,000
-99.0%
660
-98.7%
0.00%
-100.0%
Q2 2020$6,483,000
+3977.4%
50,597
+2595.6%
0.01%
Q1 2020$159,000
-97.1%
1,877
-96.5%
0.00%
-100.0%
Q4 2019$5,565,000
-5.4%
53,218
+4.1%
0.00%
-20.0%
Q3 2019$5,881,000
-60.4%
51,118
-40.7%
0.01%
-61.5%
Q2 2019$14,853,000
+63.2%
86,158
+59.5%
0.01%
+62.5%
Q1 2019$9,103,000
-8.3%
54,007
-47.0%
0.01%
-20.0%
Q4 2018$9,930,000
-48.6%
101,949
-8.9%
0.01%
-33.3%
Q3 2018$19,326,000
+7508.7%
111,875
+6030.1%
0.02%
Q2 2018$254,000
+24.5%
1,825
+0.6%
0.00%
Q1 2018$204,000
-41.2%
1,815
-30.9%
0.00%
Q4 2017$347,000
+78.9%
2,625
+37.1%
0.00%
Q3 2017$194,000
-1.0%
1,915
-2.2%
0.00%
Q2 2017$196,000
-35.7%
1,959
-22.2%
0.00%
Q1 2017$305,000
+2672.7%
2,519
+2419.0%
0.00%
Q4 2016$11,000
-15.4%
1000.0%0.00%
Q3 2016$13,000
+44.4%
1000.0%0.00%
Q2 2016$9,000
+28.6%
1000.0%0.00%
Q1 2016$7,000
-95.7%
100
-95.7%
0.00%
Q4 2015$161,000
-20.7%
2,320
+4.5%
0.00%
Q3 2015$203,000
-25.6%
2,2200.0%0.00%
Q2 2015$273,000
+17.7%
2,220
-12.9%
0.00%
Q1 2015$232,000
+34.1%
2,5500.0%0.00%
Q4 2014$173,000
-16.0%
2,5500.0%0.00%
Q3 2014$206,000
-27.5%
2,550
-3.8%
0.00%
Q2 2014$284,000
+4633.3%
2,650
+2550.0%
0.00%
Q1 2014$6,000
+50.0%
1000.0%0.00%
Q4 2013$4,000
+100.0%
1000.0%0.00%
Q3 2013$2,000
+100.0%
1000.0%0.00%
Q2 2013$1,0001000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2017
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders